IPAC-RS is proud to announce the release of its 2022-2024 Strategic Plan.  IPAC-RS is and will remain the leading technical resource and advocate of the global orally inhaled and nasal drug product (OINDP industry). Please read our new strategic plan for information on:

​

• IPAC-RS' Mission and Purpose

• 2022-2024 Strategic Goals

• IPAC-RS Member and Associate Member Benefits

• IPAC-RS Worksteams and Activities

• Priority Topics for 2022-2024

• Details of Working Group Plans

​

See Initiatives for more information on IPAC-RS activities.